EXTON, Pa., Nov. 21 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced that Vincent Milano, vice-president, chief operating officer and chief financial officer of ViroPharma, will present at the Lazard Capital Markets Fourth Annual Healthcare Conference at 3:30 P.M. ET on Tuesday, November 27, 2007. The conference is being held at the New York Palace Hotel.
ViroPharma also announced that Michel de Rosen, president and chief executive officer of ViroPharma, will present at the 19th Annual Piper Jaffray Healthcare Conference at 4:00 P.M. ET on Wednesday, November 28, 2007. The conference is being held at the Pierre Hotel in New York.
ViroPharma's presentations will be webcast live for investors through http://www.viropharma.com and available for a period of 14 days following the conference.
About ViroPharma Incorporated
ViroPharma Incorporated is a biopharmaceutical company dedicated to the
development and commercialization of products that address serious diseases
treated by physician specialists and in hospital settings. ViroPharma
commercializes Vancocin(R), approved for oral administration for treatment
of antibiotic-associated pseudomembranous colitis caused by Clostridium
difficile and enterocolitis caused by Staphylococcus aureus, including
methicillin- resistant strains (for prescribing information, please
download the package insert at
http://www.viropharma.com/docs/Vancocin_pi_2007.htm). ViroPharma currently
focuses its drug development activities in viral diseases including
cytomegalovirus (CMV) and hepatitis C (HCV). Fo
|SOURCE ViroPharma Incorporated|
Copyright©2007 PR Newswire.
All rights reserved